Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Un-audited Financial Results (Standalone & Consolidated) of the Company for the Second Quarter and Half Year ended 30.09.2026

26.10.2026 National Stock Exchange of India Limited BSE Limited “Exchange Plaza”, Floor- 25, P J Tower, Bandra-Kurla Complex, Dalal Street, Bandra (East) Mumbai 400 051 Mumbai 400 001 SYMBOL:- EPIGRAL Scrip Code: 543332 Dear Sirs, Sub.: Intimation of the Meeting of the Board of Directors of Epigral Limited scheduled to be held on Monday, 2nd November, 2026 for consideration & approval of Un-Audited Financial Results for the Second Quarter and Half Year ended 30.09.2026. Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the meeting of the Board of Directors of the Company will be held on Monday, 2nd November, 2026, at the Registered Office of the Company, inter-alia to consider, approve and take on record the following: 1. Un-Audited Financial Results (Standalone & Consolidated) of the Company for the Second Quarter and Half Year ended 30th September, 2026 and to take on record the Limited Review Report of the Statutory Auditors thereon; and 2. Any other business with the permission of the Chair. The intimation is being given for the information of Shareholders/ Members. Thanking you, Yours faithfully, For Epigral Limited Gaurang Trivedi Company Secretary & Compliance Officer M. No. A22307